Drug
Dexketoprofen (KETAVEL 50 mg/2 ml)
Dexketoprofen (KETAVEL 50 mg/2 ml) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
Comparison of Superior Hypogastric Plexus Block and Peritoneal Bupivacaine in Pain Management
NCT06954896
completedphase_4
The Efficacy of Dexketoprofen And Methylprednisolone in the Acute Low Back Pain
NCT06932367
completednot_applicable
Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain
NCT04582032
Clinical Trials (3)
Showing 3 of 3 trials
NCT06954896
Comparison of Superior Hypogastric Plexus Block and Peritoneal Bupivacaine in Pain Management
NCT06932367Phase 4
The Efficacy of Dexketoprofen And Methylprednisolone in the Acute Low Back Pain
NCT04582032Not Applicable
Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3